Search - tctmd.com

Displaying 1 - 20 of 42

Sort: Relevancy | Date

Asundexian Reduces Recurrent Stroke Without Bleeding Risk: OCEANIC-STROKE

News Daily News

Asundexian Reduces Recurrent Stroke Without Bleeding Risk: OCEANIC-STROKE

Michael O'Riordan

November 24, 2025

No Clear Risk of Dementia After TIA: Framingham Heart Study

News Daily News

No Clear Risk of Dementia After TIA: Framingham Heart Study

July 10, 2025

Catheter Ablation for AF: Fewer Strokes, Deaths, and HF Hospitalizations

News Daily News

Catheter Ablation for AF: Fewer Strokes, Deaths, and HF Hospitalizations

July 08, 2025

PFO, Risk Factors Both Exert Influence in Younger Cryptogenic Stroke Patients

News Daily News

PFO, Risk Factors Both Exert Influence in Younger Cryptogenic Stroke Patients

April 23, 2025

Risk of Another Event Remains High for Years After TIA, Minor Stroke

News Daily News

Risk of Another Event Remains High for Years After TIA, Minor Stroke

March 26, 2025

AHA Statement Outlines Cardiac Contributions to Brain Health

News Daily News

AHA Statement Outlines Cardiac Contributions to Brain Health

October 11, 2024

News Daily News

Low Bleeding Profile With Asundexian Seen in Pooled Analysis

February 13, 2024

To Curb Secondary Event Risk, Go ‘Granular’ With Causes of TIA, Minor Stroke

News Daily News

To Curb Secondary Event Risk, Go ‘Granular’ With Causes of TIA, Minor Stroke

October 03, 2023

Subclinical Leaflet Thrombosis After TAVI Linked to Higher Mortality

News Daily News

Subclinical Leaflet Thrombosis After TAVI Linked to Higher Mortality

Michael O'Riordan

March 10, 2022

Short DAPT Bests Aspirin at Preventing Recurrent Events After Stroke, TIA

News Daily News

Short DAPT Bests Aspirin at Preventing Recurrent Events After Stroke, TIA

Yael L. Maxwell

April 29, 2021

Antiplatelets, Especially Cilostazol, Helpful in Moyamoya Arteriopathy

News Daily News

Antiplatelets, Especially Cilostazol, Helpful in Moyamoya Arteriopathy

Michael O'Riordan

February 26, 2021

Post-TIA Stroke Risk Has Come Down Over Time, but Vigilance Still Needed

News Daily News

Post-TIA Stroke Risk Has Come Down Over Time, but Vigilance Still Needed

January 28, 2021

FDA Grants Stroke Prevention Indication to Ticagrelor

News Daily News

FDA Grants Stroke Prevention Indication to Ticagrelor

November 06, 2020

Strokes Impacted as COVID-19 Hit the Northeastern US

News Daily News

Strokes Impacted as COVID-19 Hit the Northeastern US

August 10, 2020

Late Cerebrovascular Events ‘Devastating’ in TAVR-Treated Patients

News Daily News

Late Cerebrovascular Events ‘Devastating’ in TAVR-Treated Patients

Michael O'Riordan

March 11, 2020

Ticagrelor Hits Mark in Large Stroke Study: THALES Top-line Results

News Daily News

Ticagrelor Hits Mark in Large Stroke Study: THALES Top-line Results

Michael O'Riordan

January 27, 2020

Clopidogrel-Aspirin in Minor Stroke/TIA of Maximum Benefit in First 21 Days

News Daily News

Clopidogrel-Aspirin in Minor Stroke/TIA of Maximum Benefit in First 21 Days

July 09, 2019

Late Follow-up of PFO Closure for Stroke Raises Questions for Antiplatelet Duration

News Daily News

Late Follow-up of PFO Closure for Stroke Raises Questions for Antiplatelet Duration

January 22, 2019

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

News Daily News

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

Michael O'Riordan

June 20, 2018

Aspirin Use by Elderly Patients After Vascular Events Linked to More Bleeding, Especially GI Bleeds

News Daily News

Aspirin Use by Elderly Patients After Vascular Events Linked to More Bleeding, Especially GI Bleeds

Michael O'Riordan

June 14, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.